Fortress Biotech, Inc.FBIONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank64
5Y CAGR-20.1%
Year-over-Year Change
Enterprise value to sales ratio
5Y CAGR
-20.1%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.06 | +178.1% |
| 2023 | 0.38 | +271.7% |
| 2022 | 0.10 | +126.5% |
| 2021 | -0.39 | -120.9% |
| 2020 | 1.84 | -43.3% |
| 2019 | 3.25 | +69.8% |
| 2018 | 1.91 | +212.3% |
| 2017 | 0.61 | -78.9% |
| 2016 | 2.90 | -92.7% |
| 2015 | 39.64 | - |